Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.21
(0.28%)
CNY 7.21
(0.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.04 Billion CNY | -18.08% |
| 2022 | 1.27 Billion CNY | 10.24% |
| 2021 | 1.15 Billion CNY | -5.98% |
| 2020 | 1.23 Billion CNY | 18.74% |
| 2019 | 1.03 Billion CNY | 59.57% |
| 2018 | 650.13 Million CNY | 1074.45% |
| 2017 | -66.71 Million CNY | -149.18% |
| 2016 | 135.66 Million CNY | -17.15% |
| 2015 | 163.75 Million CNY | -9.07% |
| 2014 | 180.08 Million CNY | 10.92% |
| 2013 | 162.35 Million CNY | 135.94% |
| 2012 | 68.81 Million CNY | 558.79% |
| 2011 | 10.44 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.1 Billion CNY | 14.98% |
| 2024 Q3 | 595.75 Million CNY | -46.13% |
| 2024 Q1 | 962.2 Million CNY | -8.0% |
| 2023 FY | 1.04 Billion CNY | -18.08% |
| 2023 Q3 | 1.16 Billion CNY | -1.53% |
| 2023 Q4 | 1.04 Billion CNY | -10.39% |
| 2023 Q2 | 1.18 Billion CNY | 16.98% |
| 2023 Q1 | 1.01 Billion CNY | -20.63% |
| 2022 Q3 | 1.61 Billion CNY | -7.03% |
| 2022 FY | 1.27 Billion CNY | 10.24% |
| 2022 Q4 | 1.27 Billion CNY | -20.9% |
| 2022 Q2 | 1.73 Billion CNY | 37.19% |
| 2022 Q1 | 1.26 Billion CNY | 9.27% |
| 2021 Q4 | 1.15 Billion CNY | 26.89% |
| 2021 FY | 1.15 Billion CNY | -5.98% |
| 2021 Q1 | 1.09 Billion CNY | -11.05% |
| 2021 Q2 | 1.02 Billion CNY | -6.17% |
| 2021 Q3 | 912.7 Million CNY | -11.23% |
| 2020 Q4 | 1.23 Billion CNY | 7.98% |
| 2020 Q1 | 1.13 Billion CNY | 9.28% |
| 2020 Q2 | 1.36 Billion CNY | 20.53% |
| 2020 Q3 | 1.14 Billion CNY | -16.51% |
| 2020 FY | 1.23 Billion CNY | 18.74% |
| 2019 FY | 1.03 Billion CNY | 59.57% |
| 2019 Q3 | 827.37 Million CNY | 14.89% |
| 2019 Q2 | 720.11 Million CNY | 36.99% |
| 2019 Q4 | 1.03 Billion CNY | 25.39% |
| 2019 Q1 | 525.68 Million CNY | -19.14% |
| 2018 Q4 | 650.13 Million CNY | 5.33% |
| 2018 FY | 650.13 Million CNY | 1074.45% |
| 2018 Q3 | 617.26 Million CNY | -1.69% |
| 2018 Q2 | 627.85 Million CNY | -9.62% |
| 2018 Q1 | 694.66 Million CNY | 1141.2% |
| 2017 Q4 | -66.71 Million CNY | -123.3% |
| 2017 Q1 | 238.25 Million CNY | 75.62% |
| 2017 Q2 | 217.58 Million CNY | -8.68% |
| 2017 Q3 | 286.37 Million CNY | 31.62% |
| 2017 FY | -66.71 Million CNY | -149.18% |
| 2016 Q4 | 135.66 Million CNY | 157.64% |
| 2016 FY | 135.66 Million CNY | -17.15% |
| 2016 Q2 | 255.72 Million CNY | 350.6% |
| 2016 Q3 | -235.35 Million CNY | -192.04% |
| 2016 Q1 | 56.75 Million CNY | -65.34% |
| 2015 Q2 | -190.85 Million CNY | 0.0% |
| 2015 Q4 | 163.75 Million CNY | 301.0% |
| 2015 Q3 | 40.83 Million CNY | 121.4% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 163.75 Million CNY | -9.07% |
| 2014 Q4 | 180.08 Million CNY | 0.0% |
| 2014 FY | 180.08 Million CNY | 10.92% |
| 2014 Q1 | 151.51 Million CNY | 0.0% |
| 2013 FY | 162.35 Million CNY | 135.94% |
| 2012 FY | 68.81 Million CNY | 558.79% |
| 2011 FY | 10.44 Million CNY | 0.0% |